RecruitingNCT02663362

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications


Sponsor

AdventHealth Translational Research Institute

Enrollment

250 participants

Start Date

Feb 1, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body


Eligibility

Min Age: 12 YearsMax Age: 89 Years

Inclusion Criteria8

  • Male or female
  • Age 12 - 89
  • Healthy (self assessed)
  • Weight under 350lbs
  • Able to walk 50 yards without stopping
  • Able to travel to hospital for study visits
  • Able to follow a 3-step command
  • Able to remain in Magnetic Resonance (MR) scanner for up to 2 hours

Exclusion Criteria5

  • Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings.
  • Are unwilling or unable to complete the imaging procedures for the duration of the MRI scan due to claustrophobia or other reason.
  • Serious mental illness that might preclude subject's ability to comply with study treatment
  • Life expectancy of less than 1 year
  • Are pregnant or plan on becoming pregnant in the next 8 weeks.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTo evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet

Outside standard MR instrumentation there will be no interventions.


Locations(1)

Translational Research Institute for Metabolism and Diabetes

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02663362